Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / series-a-preferred-consent.docx
series-a-preferred-consent.docx
High · 1
Medium · 0
Standard · 0
WRITTEN CONSENT OF THE HOLDERS OF A MAJORITY OF THE OUTSTANDING SHARES OF SERIES A PREFERR
High
⚑ Non-compete / exclusivity restraint
WRITTEN CONSENT OF THE HOLDERS OF A MAJORITY OF THE OUTSTANDING SHARES OF SERIES A PREFERRED STOCK OF GENOME DX THERAPEUTICS INC. Action by Written Consent in Lieu of a Meeting Pursuant to Section 228 of the Delaware General Corporation Law and the Investor Rights Agreement dated March 22, 2021 Date: September 10, 2025 The undersigned holder of shares of Series A Preferred Stock (as defined below) of Genome Dx Therap